Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial Active — Not Recruiting Non-phase study NCT03034811

Persona Partial Knee Clinical Outcomes Study

Persona Partial Knee Clinical Outcomes Study — Active Not Recruiting • Non-phase study • Rheumatology • NCT03034811.

📅 22 Apr 2026 ⏱ 1 min read
Active — Not Recruiting
Check the registry for current status and eligibility criteria.
Status
Active — Not Recruiting
Phase
Non-phase study
NCT ID
NCT03034811
Start
2017-02-08
Completion
2030-09
ClinicaliQ Trial Snapshot
  • Persona Partial Knee Clinical Outcomes Study — Active Not Recruiting • Non-phase study • Rheumatology • NCT03034811.
  • Persona Partial Knee implants show good survival rates and clinical outcomes in patients needing partial knee replacement surgery.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available Persona Partial Knee System. Conditions: Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures, Conditional Revision of the Articular Surface Interventions: Persona Partial Knee system Lead Sponsor: Zimmer Biomet Planned Enrollment: 757 participants

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Osteoarthritis: Care and Management (NICE CG177)
Rheumatology · 27 Mar 2026
Offer all patients with osteoarthritis structured information about self-management, weight management, and both land-based and aquatic exercise programmes as first-line treatment before…
View guideline →
Clinical Brief
‘I’ve never been this good’ – revolutionary immune reset puts lupus in remission
Rheumatology · BBC Health · 11 Jun 2026
Emerging immune reset therapy demonstrates potential to achieve drug-free remission in lupus patients, representing a significant shift from traditional long-term immunosuppressive management…
View brief →
Clinical Brief
‘I’ve never been this good’ – revolutionary immune reset puts lupus in remission
Rheumatology · BBC Health · 11 Jun 2026
Experimental immune reset treatment has induced drug-free remission in lupus patients during clinical trials, representing a significant advancement in disease management Patients…
View brief →
Podcast
JAK Inhibitors: Updated Safety Signals, Patient Selection and Post-ORAL Surveillance
Rheumatology · 00:16:21 · 03 Apr 2026
JAK inhibitors target the JAK-STAT pathway, interrupting intracellular cytokine signalling across several inflammatory diseases. ORAL Surveillance reshaped risk assessment after higher rates…
Listen →
Guideline
Gout: Diagnosis and Management (NICE NG219)
Rheumatology · 27 Mar 2026
Diagnose acute gout clinically (sudden joint pain, erythema, swelling) and confirm with serum urate level plus polarising microscopy of synovial fluid showing…
View guideline →
Webinar
JAK Inhibitors: Updated Safety Signals, Patient Selection and Post-ORAL Surveillance
Rheumatology · 0.5 · 05 Apr 2026
Recorded webinar focused on JAK inhibitors in rheumatology and immune-mediated inflammatory disease. Reviews JAK-STAT signalling, patient selection, ORAL Surveillance safety signals, cardiovascular…
Watch webinar →